| Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial CSR Araujo, AC Medeiros-Ribeiro, CGS Saad, KR Bonfiglioli, ... Annals of the rheumatic diseases 81 (6), 889-897, 2022 | 50 | 2022 |
| Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases NE Aikawa, LVK Kupa, AC Medeiros-Ribeiro, CGS Saad, EFN Yuki, ... Annals of the rheumatic diseases 81 (7), 1036-1043, 2022 | 42 | 2022 |
| Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a … NE Aikawa, LVK Kupa, SG Pasoto, AC Medeiros-Ribeiro, EFN Yuki, ... The Lancet Rheumatology 4 (2), e113-e124, 2022 | 29 | 2022 |
| Impact of distinct therapies on antibody response to SARS‐CoV‐2 vaccine in systemic lupus erythematosus EFN Yuki, EF Borba, SG Pasoto, LP Seguro, M Lopes, CGS Saad, ... Arthritis care & research 74 (4), 562-571, 2022 | 26 | 2022 |
| Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis AC Medeiros-Ribeiro, KR Bonfiglioli, DS Domiciano, AY Shimabuco, ... Annals of the rheumatic diseases 81 (5), 710-719, 2022 | 22 | 2022 |
| Cytotoxic effects of a novel maleimide derivative on epithelial and tumor cells B Ali, LDK Kupa, CS Heluany, CC Drewes, SNS Vasconcelos, ... Bioorganic Chemistry 72, 199-207, 2017 | 21 | 2017 |
| Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2 SK Shinjo, FHC de Souza, IBP Borges, AM Dos Santos, R Miossi, ... Rheumatology 61 (8), 3351-3361, 2022 | 19 | 2022 |
| The influence of obesity on hydroxychloroquine blood levels in lupus nephritis patients T Pedrosa, LVK Kupa, SG Pasoto, NE Aikawa, EF Borba, NJC Duarte, ... Lupus 30 (4), 554-559, 2021 | 18 | 2021 |
| Strong response after fourth dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccine NE Aikawa, LVK Kupa, CA Silva, CGS Saad, SG Pasoto, EFN Yuki, ... Rheumatology 62 (1), 480-485, 2023 | 14 | 2023 |
| Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome F Signorelli, GGM Balbi, NE Aikawa, CA Silva, LVK Kupa, ... Lupus 31 (8), 974-984, 2022 | 14 | 2022 |
| Hydroquinone exposure worsens the symptomatology of rheumatoid arthritis CS Heluany, LVK Kupa, MN Viana, CM Fernandes, SHP Farsky Chemico-Biological Interactions 291, 120-127, 2018 | 13 | 2018 |
| In vivo exposure to hydroquinone during the early phase of collagen-induced arthritis aggravates the disease CS Heluany, LDVK Kupa, MN Viana, CM Fernandes, ELV Silveira, ... Toxicology 408, 22-30, 2018 | 12 | 2018 |
| SARS-CoV-2 vaccine in patients with systemic sclerosis: impact of disease subtype and therapy PD Sampaio-Barros, AC Medeiros-Ribeiro, AP Luppino-Assad, R Miossi, ... Rheumatology 61 (SI2), SI169-SI174, 2022 | 11 | 2022 |
| Inactivated SARS-CoV-2 vaccine in primary Sjögren’s syndrome: humoral response, safety, and effects on disease activity SG Pasoto, ASR Halpern, LKN Guedes, ACM Ribeiro, ENF Yuki, ... Clinical rheumatology 41 (7), 2079-2089, 2022 | 10 | 2022 |
| Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis CGS Saad, MSR Silva, PD Sampaio-Barros, JCB Moraes, CG Schainberg, ... Joint bone spine 90 (1), 105464, 2023 | 9 | 2023 |
| Role of translocator 18 KDa ligands in the activation of leukotriene B4 activated G-protein coupled receptor and toll like receptor-4 pathways in neutrophils LVK Kupa, CC Drewes, ED Barioni, CL Neves, SC Sampaio, SHP Farsky Frontiers in Pharmacology 8, 278697, 2017 | 9 | 2017 |
| Anti-SARS-CoV-2 immunogenicity decay and incident cases six months after Sinovac-CoronaVac inactivated vaccine in autoimmune rheumatic diseases patients: phase 4 prospective trial E Bonfa, C Silva, A Medeiros-Ribeiro, L Kupa, E Yuki, SSG Pasoto, ... | 8 | 2021 |
| Role of an indole-thiazolidiene PPAR pan ligand on actions elicited by G-protein coupled receptor activated neutrophils JR Santin, ID Machado, CC Drewes, LVK Kupa, RM Soares, ... Biomedicine & Pharmacotherapy 105, 947-955, 2018 | 7 | 2018 |
| Evaluation of toxicity on epithelial and tumor cells of biaryl dipeptide tyrosines SNS Vasconcelos, CC Drewes, LVK Kupa, SHP Farsky, HA Stefani European Journal of Medicinal Chemistry 114, 1-7, 2016 | 7 | 2016 |
| Lupus nephritis-related issues during COVID-19 pandemic quarantine T Pedrosa, LVK Kupa, NE Aikawa, SG Pasoto, E Bonfá, CA Silva Lupus 29 (14), 1978-1980, 2020 | 6 | 2020 |
